Revenues of Semnur Pharmaceuticals, Inc. from 22 Feb 2024 to 02 Oct 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Semnur Pharmaceuticals, Inc. quarterly Revenues in USD history and change rate from 22 Feb 2024 to 02 Oct 2024.
  • Semnur Pharmaceuticals, Inc. Revenues for the quarter ending 02 Oct 2024 was $50,000,000.
Source SEC data
View on sec.gov
Revenues, Quarterly (USD)

Semnur Pharmaceuticals, Inc. Quarterly Revenues (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $50,000,000 02 Oct 2024 10-Q 15 Aug 2025 2025 Q2
Q1 2024 $50,000,000 22 Feb 2024 10-K 02 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.